If you or a loved one are on Medicare and have been trying to access popular GLP-1 weight-loss medications, you already know the biggest hurdle: the staggering out-of-pocket cost. For years, Medicare rules strictly limited coverage for these innovative drugs when prescribed specifically for weight management.
But a massive shift is coming.
The Centers for Medicare & Medicaid Services (CMS) recently announced the Medicare GLP-1 Bridge program. Starting July 1, 2026, qualifying Medicare enrollees will be able to access select, highly sought-after GLP-1 medications—including Wegovy, Zepbound, and the newly approved Foundayo—for a flat copay of just $50 per month.
With the launch just weeks away, here is everything you need to know about who qualifies and how to prepare.
How the July 1st “Bridge” Program Works
The Medicare GLP-1 Bridge is a brand-new, nationwide demonstration program designed to make effective weight-management treatments affordable. It is scheduled to run from July 1, 2026, through December 31, 2027.
What makes this program unique is that it operates entirely outside of standard Medicare Part D coverage rules. That means your $50 monthly copay remains exactly the same, no matter what coverage phase you are in (like the deductible or catastrophic phase). Additionally, drug manufacturer coupons cannot be used to lower this $50 rate any further—but at a flat $50, it is already a historic discount for seniors.
Who Qualifies for the $50 Copay?
To be eligible for the Bridge program, you must be enrolled in a standalone Medicare Prescription Drug Plan (Part D) or a Medicare Advantage plan that includes drug coverage (MA-PD). From there, CMS has outlined specific clinical criteria based on your Body Mass Index (BMI) and health history:
- BMI of 35 or higher: Automatically qualifies for coverage under the program guidelines.
- BMI of 30 or higher: Qualifies if you have also been diagnosed with certain chronic conditions, such as heart failure (HFpEF), uncontrolled high blood pressure, or chronic kidney disease.
- BMI of 27 or higher: Qualifies if you have been diagnosed with pre-diabetes, a history of a previous heart attack, or a history of a previous stroke.
Good to Know: If you are already taking one of these medications and have already lost weight, you don’t have to worry about losing coverage. CMS evaluates your BMI based on what it was when you first started the medication, even if that was before you joined Medicare or before this program launched.
The Clear Benefit Angle: Let Us Do the Heavy Lifting
While this news is incredibly exciting, implementing a brand-new federal program means things are moving fast. Because the Bridge program bypasses traditional Part D payment structures, your doctor will need to submit a specific prior authorization request through a centralized CMS portal starting July 1st.
Navigating fast-changing drug formularies, prior authorizations, and standard plan updates can easily feel dizzying. You shouldn’t have to guess whether your current standalone Part D plan or Medicare Advantage network is fully aligned to help you hit the ground running next month.
Navigating fast-changing federal guidelines and drug formularies can be complex. At Clear Benefit Solutions, our licensed agents monitor these regulatory updates in real-time to ensure our clients remain fully informed. We are available to review your current Medicare Advantage or Part D plan, verify your specific prescription coverage, and outline the exact steps you and your physician must take ahead of the July 1st launch.
To maximize your potential savings under this program, contact Clear Benefit Solutions today for a complimentary coverage review.